Business Wire

Arthur D. Little unites international CEOs to help combat COVID-19 business threats

Share

Global management consultancy Arthur D. Little (ADL) has initiated an international platform for CEOs to exchange crisis management experiences while dealing with COVID-19. Under the motto, “Learning from each other and coping with the crisis together,” the aim of the pro bono initiative is to build a pool of experience and provide companies and public institutions with knowledge on how to deal with the COVID-19 pandemic.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200320005453/en/

Arthur D. Little has initiated an international platform for CEOs to exchange crisis management experiences while dealing with COVID-19. (Graphic: Business Wire)

Arthur D. Little has initiated an international platform for CEOs to exchange crisis management experiences while dealing with COVID-19. (Graphic: Business Wire)

To achieve this, ADL is holding one-hour conference calls with CEOs of critical infrastructures (energy, transport, telecommunications and logistics) from countries including Greater China, Singapore and Italy. The purpose of each call is for the CEO to share with other CEOs best practice on their experiences of dealing with the current COVID-19 crisis, and provide analysis of their tried, tested and effective measures. To allow all to access these crisis management experiences, ADL will shortly be publishing an in-depth report that will be fully downloadable for free from its global website.

“In challenging times, rapid and global measures are required for the effective transfer of know-how between decision-makers,” comments Ignacio García Alves, Chairman and Chief Executive Officer of Arthur D. Little. “With each country facing different stages of COVID-19, it is important for those who are just at the beginning of the crisis to learn from those who have already put effective measures in place. At ADL it has always been our mission to help CEOs to anticipate whatever disruption they might be facing to ensure business continuity. Let’s work together to defeat COVID-19 by spreading knowledge and best practice quicker than the virus!”

Karim Taga, Managing Partner of Arthur D. Little and in charge of the Global TIME (Telecommunications, Information Technology, Media and Electronics) Practice says, “After seeing how COVID-19 is affecting businesses globally, we came up with the idea of connecting international CEOs to find out how they were going about their crisis management. Our conference calls have shown how focused action is being taken during this crisis, but most importantly, we are realizing how important cohesion is – in companies, in cooperation with government measures, and with public authorities. We hope that by setting up this platform, we will be able to educate a wider audience with best practices and learnings during this very uncertain time.”

Saverio Caldani, Managing Partner of Arthur D. Little Italy and Spain, says, “Italy and Spain have both been particularly impacted by COVID-19. Although we are working remotely, our teams are doing their best to ensure our clients have the support they need as we all navigate this new virtual world. ADL’s COVID-19 report will be a game-changer, and we look forward to continuing to provide innovative and strategic solutions during these challenging times.”

Contact information

Further information from:
Cate Bonthuys
Catalyst Comms
+44 7746 546773
cate@catalystcomms.co.uk

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Customer Personal Information Is the Number One Data Protection Priority – nCipher 2020 Global Encryption Trends Study7.4.2020 10:10:00 EESTPress release

As organizations accelerate digital initiatives such as cloud and the internet of things (IoT), and data volumes and types continue to rise, IT professionals cite protection of customer personal information as their number one priority, according to the 2020 Global Encryption Trends Study from the Ponemon Institute. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200407005297/en/ The Ponemon Institute has collaborated with nCipher Security, an Entrust Datacard company and world leader in hardware security modules (HSMs), on this multinational survey of how and why organizations deploy encryption, now in its fifteenth year. Threats, drivers and priorities For the first time, protecting consumer personal information is the top driver for deploying encryption (54% of respondents), outranking compliance, which ranked fourth (47%). Traditionally compliance with regulations was the top driver for deploying encryption, but has dropp

 Yokogawa Releases AI-enabled Versions of SMARTDAC+ Paperless Recorders and Data Logging Software, and Environmentally Robust AI-enabled e-RT3 Plus Edge Computing Platform for Industry Applications7.4.2020 10:00:00 EESTPress release

Yokogawa Electric Corporation (TOKYO: 6841) announces the release of artificial intelligence (AI)-enabled versions of the GX series panel-mount type paperless recorders, GP series portable paperless recorders, and GA10 data logging software, which are components of the highly operable and expandable SMARTDAC+TM data acquisition and control system. This new AI functionality includes the future pen, a function developed by Yokogawa that enables the drawing of predicted waveforms. Yokogawa is also releasing a new CPU module for the e-RT3TM Plus edge computing platform that is environmentally robust and PythonTM*1 compatible. The GX/GP and e-RT3 Plus release is set for April 8, and the GA10 software will be released on May 13. The SMARTDAC+ system is a product in the OpreXTM Data Acquisition family, and the e-RT3 Plus is part of the OpreX Control Devices family. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200407005269/en/ (to

Bank Otkritie first financial company in Russia to harness 32G FC with ADVA FSP 30007.4.2020 10:00:00 EESTPress release

ADVA (FSE: ADV) today announced that Bank Otkritie has deployed its FSP 3000 to enable 32Gbit/s Fibre Channel as well as 40 and 100Gbit/s Ethernet services. One of Russia's largest commercial financial companies, Bank Otkritie is the first bank in the country to leverage Gen 6 Fibre Channel technology. Featuring the ADVA OpenFabric™ OTN cross-connect for enhanced availability, the data center interconnect (DCI) solution delivers a new level of capacity and reliability. Comprehensive, in-service assurance and rapid failure detection capabilities are provided by the ADVA ALM fiber monitoring system. ADVA’s Select partner, the IT solution specialist Zettaline, also played a key role in facilitating the project. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200407005043/en/ ADVA's playing a key role in helping Bank Otkritie transport its mission-critical data (Photo: Business Wire) “As one of Russia’s leading banks, it’s vital

Relief Therapeutics (RLF:SIX) Drug Aviptadil Enters FDA Trial at University of Miami, to Treat COVID-19-induced Respiratory Distress7.4.2020 08:30:00 EESTPress release

RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” announces that its drug Aviptadil has now entered FDA clinical trials at the University of Miami Miller School of Medicine for the treatment of Acute Respiratory Distress Syndrome (ARDS) in COVID-19. The trial will enroll patients who are already on mechanical ventilation in the hopes that Aviptadil can decrease mortality in this condition and help to improve the ability of the patient’s lung to transfer oxygen to the body. The trial is being led by Relief’s US partner, NeuroRx, Inc., Headquartered in Radnor, PA under FDA Investigational New Drug clearance, as part of the FDA’s Corona Treatment Acceleration Program (CTAP). Details are posted on clinicaltrials.gov NCT04311697. The principal investigator for the University of Miami study site is Dr. Dushyantha Jayaweera, professor of medicine. The Co-Principal Investigators are Dr. Daniel H. Kett, professor of medicine, and Dr. Daniel Dante Yeh, associate professor of surgery at the Unive

IWBI Announces New Co-chairs and More than 225 Members of the Task Force on COVID-19 and Other Respiratory Infections: Prevention and Preparedness, Resilience and Recovery7.4.2020 00:03:00 EESTPress release

The International WELL Building Institute (IWBI) today announced the addition of four renowned industry, academic and public health leaders from the U.S., United Kingdom, China and Singapore as the newest co-chairs of its Task Force on COVID-19 and other Respiratory Infections: Prevention and Preparedness, Resilience and Recovery. They join expert co-chairs from the U.S. and others from China who will help define the critical role buildings, organizations and communities play in reducing the health burden from this and other infectious diseases. Adding to the expertise of the Task Force as co-chairs are Despina Katsikakis, international partner and head of occupier business performance at Cushman & Wakefield; Dr. Wang Qingqin, vice president of China Academy of Building Science (CABR); Dr. Lam Khee Poh, Provost's Chair professor of Architecture and Building and dean, School of Design And Environment, National University of Singapore, and Joanne Mahoney, chief operating officer at the S

CORRECTING and REPLACING Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy6.4.2020 20:58:00 EESTPress release

Please replace the release with the following corrected version due to multiple revisions to the Octapharma boilerplate and inclusion of additional multimedia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200406005285/en/ GLOBAL PLASMA LEADERS COLLABORATE TO ACCELERATE DEVELOPMENT OF POTENTIAL COVID-19 HYPERIMMUNE THERAPY Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19 Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) to develop a potential plasma-derived therapy for treating COVID-19. The alliance will begin immediately with the investigational development of one, unbranded anti-SARS-CoV-2 polyclonal hyperimmune immunoglobulin medicine with the potential to treat individuals with serious complic

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom